Top 5 Clinical Pulmonary Medicine NetWork in May

Here are the top five picks for May 2017 from the Clinical Pulmonary Medicine NetWork.


  1. 1. Adult patients with bronchiectasis: a first look at the US Bronchiectasis Research Registry
  2. The US Bronchiectasis Research Registry provides the reader with a deeper understanding of bronchiectasis stratification based on non-tuberculous mycobacteria (NTM) status.
  3. 2. Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
  4. This randomized controlled trial found a longer remission time and lesser steroid use in patients with Churg-Strauss vasculitis treated with mepolizumab.
  5. 3. Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A (H3N2) Infection: An Open-label Randomized, Controlled, Phase IIb/III Trial.
  6. 4. Effect of Home Noninvasive Ventilation With Oxygen Therapy vs Oxygen Therapy Alone on Hospital Readmission or Death After an Acute COPD Exacerbation: A Randomized Clinical Trial.
  7. This study proposed the use of home NIV, in a selected group of COPD patients, as a useful intervention to decrease COPD readmission rates and mortality.
  8. 5. Functional and Exercise Limitations After a First Episode of Pulmonary Embolism: Results of the ELOPE prospective cohort study.
  9. This prospective study proposes the use of CPET and 6MWT as reliable tools to predict exercise limitation one year after suffering from pulmonary embolism.